Tachykinins in endocrine tumors and the carcinoid syndrome

Janet L Cunningham1, Eva T Janson, Smriti Agarwal

  • 1Departments of Medical Sciences Genetics and Pathology, University Hospital, SE 751 85 Uppsala, Sweden. janet.cunningham@medsci.uu.se

Abstract

Insights

Tachykinin (TK) is synthesized in serotonin-producing tumors. Elevated plasma TK levels correlate with carcinoid syndrome symptoms like diarrhea and flush, independent of other markers.

Area of Science:

  • Endocrinology
  • Oncology
  • Gastroenterology

Background:

  • Neuroendocrine tumors, particularly metastatic ileocecal serotonin-producing carcinoid tumors (MSPCs), can cause debilitating symptoms like diarrhea and flush.
  • The role of tachykinin (TK) in these symptoms is not fully understood, though it is known to be involved in neurotransmission and inflammation.

Purpose of the Study:

  • To investigate TK expression in endocrine tumors using a novel antibody.
  • To determine the association between plasma TK levels and the severity of diarrhea and flush in patients with MSPCs.

Main Methods:

  • Immunohistochemistry was used to assess TK, serotonin, and chromogranin A (CgA) immunoreactivity in tumor tissues.
  • Plasma TK (P-TK), CgA, and urinary 5-hydroxyindoleacetic acid (U-5HIAA) levels were measured in MSPC patients and correlated with symptom frequency.

Main Results:

  • TK expression was observed in all serotonin-producing tumors, including MSPCs, but not in other endocrine tumors.
  • Elevated P-TK, P-CgA, and U-5HIAA levels were associated with daily episodes of flush or diarrhea.
  • P-TK levels showed an independent correlation with daily diarrhea, irrespective of U-5HIAA and CgA levels.

Conclusions:

  • TK synthesis occurs in serotonin-producing tumors, and plasma TK levels are significantly correlated with flush and diarrhea in MSPC patients.
  • This study is the first to report an independent correlation between P-TK and carcinoid diarrhea, challenging the sole attribution to serotonin.
  • Further research into TK may reveal new therapeutic strategies for carcinoid syndrome.

Related Concept Videos

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists01:28

Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists

Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy.  SP binds and activates these...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Metastasis02:30

Metastasis

Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...